» Articles » PMID: 25005439

Amyloid Burden, Neuroinflammation, and Links to Cognitive Decline After Ischemic Stroke

Overview
Journal Stroke
Date 2014 Jul 10
PMID 25005439
Citations 65
Authors
Affiliations
Soon will be listed here.
Citing Articles

Blood biomarkers for vascular cognitive impairment based on neuronal function: a systematic review and meta-analysis.

Huang W, Liao L, Liu Q, Ma R, He X, Du X Front Neurol. 2025; 16:1496711.

PMID: 39990267 PMC: 11842260. DOI: 10.3389/fneur.2025.1496711.


The Dipeptidyl Peptidase-4 Inhibitor Saxagliptin as a Candidate Treatment for Disorders of Consciousness: A Deep Learning and Retrospective Clinical Analysis.

Toker D, Chiang J, Vespa P, Schnakers C, Monti M Neurocrit Care. 2025; .

PMID: 39904872 DOI: 10.1007/s12028-025-02217-0.


Dementia after Ischemic Stroke, from Molecular Biomarkers to Therapeutic Options.

Dammavalam V, Rupert D, Lanio M, Jin Z, Nadkarni N, Tsirka S Int J Mol Sci. 2024; 25(14).

PMID: 39063013 PMC: 11276729. DOI: 10.3390/ijms25147772.


CCN1 Is a Therapeutic Target for Reperfused Ischemic Brain Injury.

Lee G, Chang Y, Lai J, Chang T, Huang S, Yang C Transl Stroke Res. 2024; .

PMID: 39028413 DOI: 10.1007/s12975-024-01279-0.


Systemic immune-inflammation index upon admission correlates to post-stroke cognitive impairment in patients with acute ischemic stroke.

Cheng Y, Zhu H, Liu C, Li L, Lin F, Guo Y Aging (Albany NY). 2024; 16(10):8810-8821.

PMID: 38771141 PMC: 11164514. DOI: 10.18632/aging.205839.